Bristol-Myers Squibb shares significant new findings in rheumatoid arthritis research
Global biopharma company, Bristol-Myers Squibb, will present new data and offer insights into the field of rheumatoid arthritis at the Annual European Congress of Rheumatology (EULAR 2016) this week.
Click on this link for more information.
